trimethylethylammonium

RN given refers to parent cpd

Also Known As:

TMEA chloride; ethyltrimethylammonium; trimethylethylammonium acetate; trimethylethylammonium bromide; trimethylethylammonium chloride; trimethylethylammonium hydroxide; trimethylethylammonium iodide; trimethylethylammonium sulfite (1:1)

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Nitrogen Compounds: 67
  - Ammonium Compounds: 1606
    - Quaternary Ammonium Compounds: 136
      - trimethylethylammonium: 4
Organic Chemicals: 133
- Amines: 4871
  - Quaternary Ammonium Compounds: 136
    - trimethylethylammonium: 4
- Onium Compounds
  - Quaternary Ammonium Compounds: 136
    - trimethylethylammonium: 4

Experts

1.	Chen, Ling: 1 article (01/2022)
2.	Cheng, Peng: 1 article (01/2022)
3.	Cheng, Wen: 1 article (01/2022)
4.	Cui, Xiao: 1 article (01/2022)
5.	Liang, Qingyu: 1 article (01/2022)
6.	Liu, Tianqi: 1 article (01/2022)
7.	Ren, Xiufang: 1 article (01/2022)
8.	Shen, Shuai: 1 article (01/2022)
9.	Wu, Anhua: 1 article (01/2022)
10.	Wu, Jianqi: 1 article (01/2022)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2022 - "Blocking the chemerin/CMKLR1 axis with 2-(α-naphthoyl) ethyltrimethylammonium iodide disrupted the mesenchymal network and suppressed tumor growth in GBM. "
2.	Inflammation (Inflammations) 01/01/2022 - "Most importantly, 2-(α-naphthoyl) ethyltrimethylammonium iodide (α-NETA), a small molecule antagonist for CMKLR1, was evidenced to exhibit profound anti-endometriosis effects (anti-growth, anti-mesenchymal features, anti-angiogenesis, and anti-inflammation) in vitro and in vivo. "
3.	Hypertension (High Blood Pressure) 01/01/2019 - "Furthermore, CMKLR1 inhibition via α-NETA (2-[α-naphthoyl] ethyltrimethylammonium iodide) treatment significantly attenuated renal immune cell infiltration, hypertension, and renal damage in SS rats fed high salt. "
4.	Endometriosis 01/01/2022 - "Most importantly, 2-(α-naphthoyl) ethyltrimethylammonium iodide (α-NETA), a small molecule antagonist for CMKLR1, was evidenced to exhibit profound anti-endometriosis effects (anti-growth, anti-mesenchymal features, anti-angiogenesis, and anti-inflammation) in vitro and in vivo. "
5.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/01/2019 - "We previously reported that chemerin receptor chemokine-like receptor 1 (CMKLR1) is required for maximal clinical and histological experimental autoimmune encephalomyelitis (EAE); and identified CMKLR1 small molecule antagonist 2-(α-naphthoyl) ethyltrimethylammonium iodide (α-NETA) that significantly suppressed disease onset in vivo. "

Related Drugs and Biologics

1.	Iodides
2.	Chemokine Receptors
3.	Salts